Clinical Gastroenterology and Hepatology最新文献

筛选
英文 中文
Determining Cirrhosis Status in Candidates for Resmetirom. 瑞司替罗患者肝硬化状态的测定。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.022
Mazen Noureddin, Mena Bansal, Mary E Rinella
{"title":"Determining Cirrhosis Status in Candidates for Resmetirom.","authors":"Mazen Noureddin, Mena Bansal, Mary E Rinella","doi":"10.1016/j.cgh.2025.04.022","DOIUrl":"10.1016/j.cgh.2025.04.022","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143971408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Index of Severity for Eosinophilic Esophagitis Helps Predict Treatment Response to Dupilumab. 嗜酸性粒细胞性食管炎的严重程度指数有助于预测dupilumab的治疗反应。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.016
Corey J Ketchem, Anwesh Dash, Gary W Falk, Evan S Dellon, Kristle L Lynch
{"title":"The Index of Severity for Eosinophilic Esophagitis Helps Predict Treatment Response to Dupilumab.","authors":"Corey J Ketchem, Anwesh Dash, Gary W Falk, Evan S Dellon, Kristle L Lynch","doi":"10.1016/j.cgh.2025.04.016","DOIUrl":"10.1016/j.cgh.2025.04.016","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143961241","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Refining Donor Selection for FMT in UC: The Role of Chromobacteriaceae and Other Underrecognized Pro-inflammatory Taxa. 改进UC中FMT的供体选择:色杆菌科和其他未被认识的促炎类群的作用。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.019
Hong Zhang, Jiaxin Li, Hu Zhang
{"title":"Refining Donor Selection for FMT in UC: The Role of Chromobacteriaceae and Other Underrecognized Pro-inflammatory Taxa.","authors":"Hong Zhang, Jiaxin Li, Hu Zhang","doi":"10.1016/j.cgh.2025.04.019","DOIUrl":"10.1016/j.cgh.2025.04.019","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143968306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome. 肝硬化患者的动态急性肾损伤是常见和繁重的。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.03.015
Kavish R Patidar, Ruben Hernaez, Yan Liu, George Cholankeril, Jennifer R Kramer, Thom Taylor, Prasun Jalal, Tzu-Hao Lee, Avegail G Flores, Giuseppe Cullaro, Andrew S Allegretti, Pere Gines, Fasiha Kanwal
{"title":"Ambulatory Acute Kidney Injury in Patients With Cirrhosis Is Common and Burdensome.","authors":"Kavish R Patidar, Ruben Hernaez, Yan Liu, George Cholankeril, Jennifer R Kramer, Thom Taylor, Prasun Jalal, Tzu-Hao Lee, Avegail G Flores, Giuseppe Cullaro, Andrew S Allegretti, Pere Gines, Fasiha Kanwal","doi":"10.1016/j.cgh.2025.03.015","DOIUrl":"10.1016/j.cgh.2025.03.015","url":null,"abstract":"<p><strong>Background & aims: </strong>Little is known about ambulatory acute kidney injury (A-AKI), which develops in an outpatient setting.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of patients diagnosed with cirrhosis between January 1, 2018, and December 31, 2019 from 130 hospitals in the Veterans Affairs healthcare system. Patients were classified as having incident A-AKI if they met the International Club of Ascites AKI criteria in an outpatient setting. We used multivariable regression models to identify factors associated with A-AKI development within 1 year of cirrhosis diagnosis. We also conducted a structured implicit review of patients' medical charts to determine the precipitants of A-AKI. We examined the rates of AKI-resolution, hemodialysis and death at 90 days.</p><p><strong>Results: </strong>Among 55,880 patients with cirrhosis [median age 66 years, 38% alcohol-related cirrhosis (alcohol-associated liver disease), median Model for End-Stage Liver Disease-Sodium 10, 34% ascites] followed for a median of 3.4 years, 6889 (12%) patients developed incident A-AKI. Patients with ascites (odds ratio [OR], 2.51), Model for End-Stage Liver Disease-Sodium >15 (OR, 1.58), hepatocellular carcinoma (OR, 1.45) or alcohol-associated liver disease (OR, 1.37) had higher odds of developing A-AKI. In total, 60% had AKI-resolution, 4.5% progressed to hemodialysis, and 12% died within 90 days of A-AKI onset. In a review of medical records of 250 randomly selected patients with A-AKI, key precipitants were hypovolemia due to diuretics and gastrointestinal losses, and nephrotoxin medication exposure. Overall, 42% of A-AKI events were unrecognized.</p><p><strong>Conclusions: </strong>A-AKI is common in cirrhosis, associated with high 90-day mortality, and significantly under-recognized. Targeted interventions for early diagnosis and treatment could improve outcomes in high-risk patients.</p>","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143969043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconsidering the Relationship Between Early Post Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy and Mortality: Are We Still Missing Something? “重新考虑tips术后早期肝性脑病与死亡率之间的关系:我们是否还遗漏了什么?”
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.020
Dario Saltini, Silvia Nardelli, Filippo Schepis
{"title":"Reconsidering the Relationship Between Early Post Transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy and Mortality: Are We Still Missing Something?","authors":"Dario Saltini, Silvia Nardelli, Filippo Schepis","doi":"10.1016/j.cgh.2025.04.020","DOIUrl":"10.1016/j.cgh.2025.04.020","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143967836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Iron Pill Gastritis. 铁丸胃炎。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.03.010
Grace Meulman, Joo-Shik Shin, Emily Nash
{"title":"Iron Pill Gastritis.","authors":"Grace Meulman, Joo-Shik Shin, Emily Nash","doi":"10.1016/j.cgh.2025.03.010","DOIUrl":"10.1016/j.cgh.2025.03.010","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143961239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verrucous Carcinoma of the Esophagus. 食道疣状癌。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.03.013
D Chamil Codipilly, Cadman L Leggett
{"title":"Verrucous Carcinoma of the Esophagus.","authors":"D Chamil Codipilly, Cadman L Leggett","doi":"10.1016/j.cgh.2025.03.013","DOIUrl":"10.1016/j.cgh.2025.03.013","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143955346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply. 答复:改进脂肪变性肝病中结直肠癌的风险评估:对方法学挑战的见解。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.03.014
Takefumi Kimura, Nobuharu Tamaki, Masayuki Kurosaki
{"title":"Reply.","authors":"Takefumi Kimura, Nobuharu Tamaki, Masayuki Kurosaki","doi":"10.1016/j.cgh.2025.03.014","DOIUrl":"10.1016/j.cgh.2025.03.014","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143985763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016. 1969年至2016年间瑞典全国人群胆囊切除术后的长期死亡率。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.015
Louise Emilsson, Amit D Joshi, Jonas F Ludvigsson
{"title":"Long-Term Mortality After Cholecystectomy in a Nationwide Cohort of Swedish Individuals Between 1969 and 2016.","authors":"Louise Emilsson, Amit D Joshi, Jonas F Ludvigsson","doi":"10.1016/j.cgh.2025.04.015","DOIUrl":"10.1016/j.cgh.2025.04.015","url":null,"abstract":"<p><strong>Background and aims: </strong>Few studies have reported overall and subgroup long-term survival after cholecystectomy.</p><p><strong>Methods: </strong>Linking gallbladder histopathology reports from all of Sweden's 28 pathology departments to the Swedish Patient Register, we identified 159,946 adults 20-79 years of age with incident cholecystectomy between 1969 and 2016. Each patient was age- and sex- matched to 5 general population reference individuals (N = 764,681). Cox regression hazard ratios were conditioned on matching factors and additionally adjusted for type 2 diabetes, obesity, ischemic heart disease, chronic obstructive pulmonary disease, alcohol-related diseases, and education.</p><p><strong>Results: </strong>During a median follow-up of 12 years, we identified 38,401 deaths (18.5 deaths per 1000 person-years [PY]) among cholecystectomy participants and 181,197 deaths in reference individuals (18.4 per 1000 PY). This corresponded to an adjusted hazard ratio (aHR) of 0.91 (95% confidence interval [CI], 0.90-0.92) for overall mortality, and low cardiovascular mortality (aHR, 0.85; 95% CI, 0.83-0.86), which highly heterogeneous by age. Cholecystectomy was associated with higher mortality in individuals 20-39 years of age, with absolute mortality rates of 2.1 (95% CI, 1.9-2.2) in cholecystectomy participants vs 1.4 (95% CI, 1.3-1.4) per 1000 PY in reference individuals. Alcohol-related disease (12.2%) and smoking-related disorders (7.4%) were common among the 1015 patients diagnosed at 20-39 years of age who died during follow-up. Individuals >50 years of age undergoing cholecystectomy had a lower relative risk of overall and cardiovascular mortality. Cholecystectomy was not associated with cancer mortality (aHR, 1.01; 95% CI, 0.99-1.03).</p><p><strong>Conclusions: </strong>In a nationwide, Swedish cohort, we observed that cholecystectomy at younger age was associated with higher long-term mortality, potentially influenced by higher alcohol use and smoking. The inverse association among individuals >50 years of age may reflect better underlying health of individuals selected for cholecystectomy.</p>","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143980882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
American Gastroenterological Association Policy Priorities for Our 2025 Legislative Agenda. 美国胃肠病学协会2025年立法议程的政策优先事项。
IF 11.6 1区 医学
Clinical Gastroenterology and Hepatology Pub Date : 2025-05-10 DOI: 10.1016/j.cgh.2025.04.021
Omeed Alipour, Sheila D Rustgi, Kathleen Teixeira, Leslie Narramore, Shazia Mehmood Siddique
{"title":"American Gastroenterological Association Policy Priorities for Our 2025 Legislative Agenda.","authors":"Omeed Alipour, Sheila D Rustgi, Kathleen Teixeira, Leslie Narramore, Shazia Mehmood Siddique","doi":"10.1016/j.cgh.2025.04.021","DOIUrl":"10.1016/j.cgh.2025.04.021","url":null,"abstract":"","PeriodicalId":10347,"journal":{"name":"Clinical Gastroenterology and Hepatology","volume":" ","pages":""},"PeriodicalIF":11.6,"publicationDate":"2025-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143966824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信